(Total Views: 87)
Posted On: 05/16/2019 3:30:42 PM
Post# of 25499

$RHHBY News Article - Roche's personalised medicine entrectinib shrank tumours harbouring NTRK, ROS1 or ALK gene fusions in children and adolescents https://marketwirenews.com/news-releases/roch...96132.html


My Twitter: WhyteStocks